Atrial Fibrillation Risk in Menopause: What Actually Changes After 45

Atrial fibrillation (AFib) is a heart rhythm disorder in which the upper chambers of the heart beat irregularly and often rapidly, rather than in the coordinated pattern of a normal heartbeat. Its incidence rises with age in both men and women, but research tracking women through the menopause transition has found that the timing of menopause itself, not just chronological age, matters for long-term risk.

Studies following large cohorts of women have found that those who go through natural menopause at a younger age tend to have a higher lifetime risk of developing AFib compared with those who reach menopause later, suggesting that cumulative years of estrogen exposure play a role independent of age alone. This lines up with a broader pattern seen across cardiovascular health in menopause, also discussed in our guide to [menopause and heart disease risk](/blog/menopause-heart-disease-risk-what-swan-found).

The proposed mechanism involves estrogen's effects on the heart's electrical conduction system and on the atria themselves, along with its broader role in maintaining blood vessel flexibility and reducing inflammation, both of which are relevant to how easily an irregular rhythm can take hold.

This is one of the most common sources of confusion, since both can feel like a racing or pounding heart. Ordinary menopausal palpitations, discussed in depth in [menopause heart palpitations](/blog/menopause-heart-palpitations-why-your-heart-races-and-what-helps), are usually brief, tend to happen around a hot flash, and typically resolve within a minute or two, with the underlying rhythm still regular even though it feels forceful.

AFib feels different in a few key ways: the rhythm itself is irregular, often described as chaotic or unpredictable rather than just fast, episodes can last much longer, from many minutes to hours or longer, and it's more likely to come with shortness of breath, lightheadedness, or a sense of the heart "fluttering" rather than simply pounding.

Because these can genuinely be hard to distinguish by feel alone, any new palpitation pattern that's irregular, prolonged, or accompanied by shortness of breath, chest discomfort, or fainting warrants a call to a doctor rather than an assumption that it's "just menopause."

Menopause timing is one factor among several, and for most women, traditional cardiovascular risk factors matter just as much or more. High blood pressure, obesity, diabetes, heavy alcohol use, and untreated sleep apnea are all well-established AFib risk factors that become more common or more consequential in midlife.

Sleep apnea deserves particular attention because it's frequently underdiagnosed in women, whose symptoms can look different from the classic male presentation, and untreated sleep apnea is strongly linked to AFib risk through repeated oxygen drops and pressure changes in the chest during sleep. If snoring, gasping during sleep, or unexplained daytime fatigue are present, it's worth raising with a doctor alongside any heart rhythm concerns.

Family history also plays a meaningful role; a first-degree relative with AFib increases individual risk independent of other factors, which is useful context to bring to a cardiology or primary care conversation about your own risk profile.

The standard first step is an electrocardiogram (EKG), a quick, painless test that records the heart's electrical activity and can confirm or rule out AFib if it happens to be occurring during the test. Because AFib can be intermittent, especially in its early stages, a single normal EKG doesn't fully rule it out if symptoms are still a concern.

For intermittent symptoms, doctors often use extended monitoring: a Holter monitor worn for 24-48 hours, or a longer-term patch monitor worn for one to two weeks, to capture an episode as it happens. Consumer smartwatches with heart rhythm features have also become a reasonable early screening tool, though an abnormal reading from a wearable should always be confirmed with a medical-grade EKG rather than treated as a diagnosis on its own.

Once diagnosed, AFib management typically involves addressing stroke risk, since AFib significantly increases stroke risk by allowing blood to pool and clot in the heart, alongside treatments to control heart rate or rhythm directly.

Many of the same steps that support overall cardiovascular health in menopause also reduce AFib risk specifically. Managing blood pressure, maintaining a healthy weight, treating sleep apnea if present, and limiting alcohol intake are all supported by strong evidence for reducing AFib risk and recurrence.

Regular moderate exercise supports heart health broadly, though very high-volume endurance exercise has been linked to slightly increased AFib risk in some studies, so moderate, consistent activity, discussed in our guide to [resistance training for menopause](/blog/resistance-training-for-menopause-why-lifting-matters), is generally the better target than extreme endurance training.

Whether hormone therapy itself affects AFib risk is genuinely mixed in the research, with some studies suggesting a modest risk difference depending on timing and formulation; this is a nuanced, individual conversation to have with a doctor rather than a reason to avoid or seek out HRT based on AFib risk alone. See [HRT and heart health](/blog/menopause-heart-disease-risk-what-swan-found) for more on how hormone therapy fits into overall cardiovascular risk.

If you've noticed new palpitations or you're trying to understand your personal cardiovascular risk factors heading into or through menopause, [ask Lea](https://meetlea.ai/chat?q=Could+my+palpitations+be+atrial+fibrillation+and+what+should+I+ask+my+doctor%3F) to help you prepare specific questions for your next appointment.